|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 18.20 SEK | +2.13% |
|
-1.52% | -19.47% |
| 07-20 | SynAct Pharma Draws SEK50 Million from New Financing Facility | MT |
| 07-20 | Synact Pharma secures access to financing of up to €9.0m | FW |
| Market Cap | 998M 104M 90.77M 84.29M 77.73M 146M 9.98B 149M 391M 4.95B 392M 384M 16.66B | P/E 2026 * |
-12x | P/E 2027 * | -23.4x |
|---|---|---|---|---|---|
| Enterprise Value | 980M 103M 89.18M 82.81M 76.37M 144M 9.8B 146M 384M 4.87B 386M 377M 16.37B | EV / Sales 2026 * |
7.07x | EV / Sales 2027 * | 48.4x |
| Free-Float |
70.28% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: SynAct Pharma AB
| 1 day | +2.13% | ||
| 1 week | -1.52% | ||
| Current month | -13.54% | ||
| 1 month | -8.17% | ||
| 3 months | +7.06% | ||
| 6 months | -15.15% | ||
| Current year | -19.47% |
| 1 week | 17.08 |  | 18.9 |
| 1 month | 17.08 | | 23.5 |
| Current year | 7.05 | | 24.4 |
| 1 year | 7.05 | | 25.3 |
| 3 years | 4.98 | | 124.6 |
| 5 years | 4.98 | | 146 |
| 10 years | 4.8 | | 146 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jeppe Øvlesen
CEO | Chief Executive Officer | 64 | 01/01/2014 |
Ann Kristin Led
DFI | Director of Finance/CFO | - | 01/03/2026 |
Kirsten Harting
CTO | Chief Tech/Sci/R&D Officer | - | 15/02/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Jeppe Øvlesen
BRD | Director/Board Member | 64 | 20/03/2024 |
Anders Kronborg
CHM | Chairman | 62 | 20/03/2024 |
Sten Scheibye
BRD | Director/Board Member | 74 | 20/03/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 6/3/26 | Buy | Chief Operating Officer | 2,750 | 0.0052% | ||
| 31/12/25 | Buy | Chief Technology Officer | 3,529 | 0.0066% | ||
| 22/12/25 | Buy | Executive/Senior Manager | 1,500 | 0.0028% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.13% | -1.52% | -17.65% | -80.04% | 104M | |
| -2.77% | -6.10% | +51.75% | +147.07% | 1,030B | |
| -0.34% | -3.63% | +54.08% | +51.51% | 617B | |
| -2.06% | -3.08% | +32.98% | +68.04% | 455B | |
| -0.16% | -0.76% | +37.07% | +30.23% | 350B | |
| -0.32% | -0.65% | +33.86% | +38.44% | 299B | |
| -0.86% | -0.62% | +11.20% | +12.57% | 265B | |
| -7.83% | -5.35% | -3.51% | -44.43% | 225B | |
| -1.38% | +1.00% | +28.70% | +62.20% | 209B | |
| -1.25% | -0.10% | +15.04% | +69.66% | 163B | |
| Average | -1.46% | +3.47% | +24.35% | +35.53% | 361.28B | |
| Weighted average by Cap. | -1.84% | +4.87% | +37.46% | +70.28% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 139M 14.53M 12.62M 11.72M 10.81M 20.36M 1.39B 20.73M 54.33M 689M 54.56M 53.37M 2.32B | 21.15M 2.21M 1.92M 1.79M 1.65M 3.1M 211M 3.16M 8.28M 105M 8.32M 8.14M 353M |
| Net income | 52.18M 5.46M 4.75M 4.41M 4.06M 7.66M 522M 7.79M 20.43M 259M 20.52M 20.07M 871M | -26.04M -2.73M -2.37M -2.2M -2.03M -3.82M -260M -3.89M -10.2M -129M -10.24M -10.02M -435M |
| Net Debt | -17.48M -1.83M -1.59M -1.48M -1.36M -2.56M -175M -2.61M -6.84M -86.79M -6.87M -6.72M -292M | 24.86M 2.6M 2.26M 2.1M 1.94M 3.65M 249M 3.71M 9.73M 123M 9.78M 9.56M 415M |
Employees
8
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 31/07/26 | SEK 18.20 | +2.13% | 125,868 |
| 30/07/26 | SEK 17.82 | +2.41% | 154,259 |
| 29/07/26 | SEK 17.40 | +1.40% | 195,104 |
| 28/07/26 | SEK 17.16 | -6.02% | 287,766 |
| 27/07/26 | SEK 18.26 | -1.19% | 97,909 |
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SYNACT Stock
Select your edition
All financial news and data tailored to specific country editions
